Table 1.
Comparison of clinical characteristics between MASLD and non-MASLD groups.
| Characteristics | Total (n = 957) | MASLD (n = 540) | Non-MASLD (n = 417) | P value |
|---|---|---|---|---|
| Age (year) | 54.0 ± 8.1 | 53.9 ± 8.2 | 54.0 ± 8.1 | 0.972 |
| Male, n (%) | 483 (50.5) | 279 (51.7) | 204 (48.9) | 0.400 |
| Duration (year) | 7.7 ± 3.1 | 7.8 ± 3.2 | 7.7 ± 3.0 | 0.539 |
| BMI (kg/m2) | 24.2 ± 3.0 | 25.3 ± 3.1 | 22.9 ± 2.4 | < 0.001 |
| WC (cm) | 85.3 ± 6.9 | 87.7 ± 7.0 | 82.1 ± 5.5 | < 0.001 |
| SBP (mmHg) | 132.8 ± 18.1 | 139.1 ± 16.9 | 124.7 ± 14.6 | < 0.001 |
| DBP (mmHg) | 81.4 ± 9.3 | 84.5 ± 8.5 | 77.3 ± 8.9 | < 0.001 |
| HbA1c (%) | 8.76 ± 1.05 | 8.76 ± 1.02 | 8.75 ± 1.09 | 0.983 |
| TG (mmol/L) | 2.18 ± 1.36 | 2.58 ± 1.46 | 1.67 ± 1.02 | < 0.001 |
| TC (mmol/L) | 5.30 ± 1.19 | 5.23 ± 1.18 | 5.38 ± 1.25 | 0.068 |
| HDL-c(mmol/L) | 1.09 ± 0.24 | 1.00 ± 0.21 | 1.20 ± 0.23 | < 0.001 |
| LDL-c(mmol/L) | 3.52 ± 0.94 | 3.56 ± 0.93 | 3.47 ± 0.95 | 0.135 |
| APOA1(g/L) | 0.99 ± 0.19 | 0.91 ± 0.17 | 1.09 ± 0.21 | < 0.001 |
| UA (umol/L) | 349.0 ± 85.1 | 369.5 ± 88.2 | 321.4 ± 73.0 | < 0.001 |
| Creatinine (umol/L) | 68.9 ± 13.1 | 68.3 ± 13.2 | 69.7 ± 12.9 | 0.105 |
| ALT (IU/L) | 37.6 ± 8.8 | 39.1 ± 9.3 | 35.7 ± 7.9 | < 0.001 |
| AST (IU/L) | 31.3 ± 6.9 | 32.3 ± 7.5 | 30.1 ± 5.7 | < 0.001 |
|
Albumin (g/L) (g/L) |
40.1 ± 4.9 | 40.0 ± 4.1 | 40.3 ± 4.6 | 0.788 |
| Platelets (109/L) | 187.1 ± 68.2 | 187.1 ± 62.7 | 189.1 ± 47.6 | 0.892 |
| Monocyte (108/L) | 4.75 ± 1.01 | 4.35 ± 1.04 | 3.89 ± 0.95 | < 0.001 |
| HOMA-IR | 3.10 ± 1.74 | 3.59 ± 1.79 | 2.46 ± 1.44 | < 0.001 |
| MAR (108/g) | 4.39 ± 1.43 | 4.93 ± 1.37 | 3.69 ± 1.17 | < 0.001 |
| MHR (108/mmol) | 4.07 ± 1.52 | 4.56 ± 1.53 | 3.43 ± 1.26 | < 0.001 |
| Hypertension, n (%) | 271 (37.2) | 253 (46.9) | 90 (21.6) | < 0.001 |
| Drinking, n (%) | 229 (29.6) | 163 (30.2) | 120 (28.8) | 0.636 |